You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

WT1 Antigen

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies, Advanced Cancer Trial in United States (ASP7517, Pembrolizumab)

Recruiting
  • Advanced Malignancies
  • Advanced Cancer
  • Atlanta, Georgia
  • +3 more
Aug 2, 2022

Tumors, Breast Trial in Worldwide (GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI)

Terminated
Has Results
  • Neoplasms, Breast
  • GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI) GSK2302024A
  • +10 more
  • Newark, Delaware
  • +35 more
Apr 30, 2021

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Multiple Myeloma Trial in New York (drug, biological, procedure)

Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 3, 2023

Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and

Completed
  • Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
    • Roma, Italy
      Servizio E Dh Di Ematologia
    Feb 23, 2023

    Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,

    Recruiting
    • Leukemia, Acute Lymphocytic (ALL)
    • +2 more
    • Chimeric antigen receptor T cells
    • peptide specific dendritic cell
    • Guangzhou, Guangdong, China
      Zhujiang Hospital, Southern Medical University
    Aug 1, 2021

    Acute Myeloid Leukemia Trial in Belgium (DC vaccine)

    Recruiting
    • Acute Myeloid Leukemia
    • DC vaccine
    • Antwerp, Belgium
    • +7 more
    Jan 15, 2021

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023

    Colorectal Cancer, Gastric Cancer, Pancreatic Cancer Trial in Huntersville, Canton (CUE-102)

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Huntersville, North Carolina
    • +1 more
    Jul 5, 2022

    HIV Trial in United States (Profectus HIV MAG pDNA vaccine, IL-12, Placebo)

    Completed
    • HIV Infections
    • Profectus HIV MAG pDNA vaccine
    • +2 more
    • Los Angeles, California
    • +12 more
    Oct 28, 2021

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Infusion of NEXI-001 T Cells
    • Duarte, California
    • +4 more
    Feb 16, 2021

    Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

    Completed
    • Multiple Myeloma
    • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
    • Standard of care
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 22, 2022

    Antigen-specific T Cells in Antisynthetase Syndrome and

    Not yet recruiting
    • Antisynthetase Syndrome
    • BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
    • Dijon, France
    • +5 more
    Aug 2, 2023

    Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • Aldesleukin
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 15, 2021

    Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

    Not yet recruiting
    • Neuroendocrine Tumor (NET)
    • Colorectal Cancer (CRC)
    • CHM-2101 CAR-T cells
    • (no location specified)
    Sep 20, 2023

    Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

    Recruiting
    • Refractory Multiple Myeloma
    • Relapsed Multiple Myeloma
    • Manufactured Anti-BCMA CAR-T cells
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Denver, Colorado
    • +1 more
    Jul 7, 2023

    COVID Infection in Pediatric Surgical Patient

    Recruiting
    • COVID-19
    • Rapid antigen test
    • Surrey, British Columbia, Canada
      Salem Anaesthesia Pain Clinic
    Jun 9, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Colonic Tumors Trial in Wuhan (neoadjuvant chemo)

    Recruiting
    • Colonic Neoplasms
    • neoadjuvant chemotherapy
    • Wuhan, Hubei, China
      Tongji Hospital, Huazhong University of Science and Technology
    Jul 19, 2022

    Advanced Pleural Malignant Mesothelioma, HLA-A*0201 Positive Cells Present, Recurrent Non-Small Cell Lung Carcinoma Trial in

    Terminated
    Has Results
    • Advanced Pleural Malignant Mesothelioma
    • +10 more
    • Aldesleukin
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 16, 2021

    Acute Myeloid Leukemia Trial in Kunming (Anti-CLL1 CART cells)

    Recruiting
    • Acute Myeloid Leukemia
    • Anti-CLL1 CART cells
    • Kunming, Yunnan, China
      No.212 Daguan Road, Xishan District
    Nov 23, 2022

    B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

    Recruiting
    • B-Cell Lymphoma
    • +4 more
    • 19(T2)28z1xx TRAC T cell
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Feb 24, 2023

    Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)

    Not yet recruiting
    • Digestive Tumor
    • TM4SF1-positive chimeric antigen receptor T-cell therapy
    • (no location specified)
    Dec 21, 2022

    Metastatic Castration-resistant Prostate Cancer Trial (TmPSMA-02)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • TmPSMA-02
    • (no location specified)
    Aug 3, 2022